SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,455,000 | -18.9% | 168,956 | +0.8% | 0.01% | -20.0% |
| Q1 2019 | $1,793,000 | +31.7% | 167,684 | +7.8% | 0.02% | +25.0% |
| Q4 2018 | $1,361,000 | -39.2% | 155,505 | +16.6% | 0.01% | -20.0% |
| Q3 2018 | $2,240,000 | -20.9% | 133,314 | -1.3% | 0.02% | -21.1% |
| Q2 2018 | $2,832,000 | +35.1% | 135,095 | +3.7% | 0.02% | +280.0% |
| Q1 2018 | $2,096,000 | -16.2% | 130,227 | -1.3% | 0.01% | -16.7% |
| Q4 2017 | $2,501,000 | +2742.0% | 131,914 | +1040.4% | 0.01% | – |
| Q2 2017 | $88,000 | +27.5% | 11,567 | +7.2% | 0.00% | – |
| Q1 2017 | $69,000 | +3.0% | 10,792 | -28.7% | 0.00% | – |
| Q4 2016 | $67,000 | +1.5% | 15,146 | +7.6% | 0.00% | – |
| Q3 2016 | $66,000 | -14.3% | 14,078 | +20.7% | 0.00% | – |
| Q2 2016 | $77,000 | 0.0% | 11,659 | -4.0% | 0.00% | – |
| Q1 2016 | $77,000 | -96.7% | 12,150 | -95.4% | 0.00% | -100.0% |
| Q4 2013 | $2,349,000 | -16.2% | 265,436 | -20.5% | 0.01% | -30.0% |
| Q3 2013 | $2,802,000 | +38.2% | 333,975 | +22.9% | 0.01% | +11.1% |
| Q2 2013 | $2,027,000 | – | 271,734 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Crestline Management, LP | 65,362 | $51,000 | 0.01% |